{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T21:28:31Z","timestamp":1785533311607,"version":"3.56.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T00:00:00Z","timestamp":1709856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T00:00:00Z","timestamp":1709856000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001279","name":"Great Ormond Street Hospital Charity","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001279","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011561","name":"Georg und Bertha Schwyzer-Winiker-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011561","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003950","name":"Wolfermann-Naegeli Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008464","name":"EMDO Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008464","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["222096\/Z\/20\/Z"],"award-info":[{"award-number":["222096\/Z\/20\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Congenital athymia is a rare T-lymphocytopaenic condition, which requires early corrective treatment with thymus transplantation (TT). Athymic patients are increasingly identified through newborn screening (NBS) for severe combined immunodeficiency (SCID). Lack of relatable information resources contributes to challenging patient and family journeys during the diagnostic period following abnormal NBS results. Patient and Public Involvement and Engagement (PPIE) activities, including parental involvement in paediatrics, are valuable initiatives to improve clinical communication and parental information strategies. Parents of infants with suspected athymia were therefore invited to discuss the information they received during the diagnostic period following NBS with the aim to identify parental information needs and targeted strategies to address these adequately. Parents reported that athymia was not considered with them as a possible differential diagnosis until weeks after initial NBS results. Whilst appropriate clinical information about athymia and TT was available upon referral to specialist immunology services, improved access to easy-to-understand information from reliable sources, including from clinical nurse specialists and peer support systems, remained desirable. A roadmap concept, with written or digital information, addressing parental needs in real time during a potentially complex diagnostic journey, was proposed and is transferrable to other inborn errors of immunity (IEI) and rare diseases. This PPIE activity provides insight into the information needs of parents of infants with suspected athymia who are identified through SCID NBS, and highlights the role for PPIE in promoting patient- and family-centred strategies to improve IEI care.<\/jats:p>","DOI":"10.1007\/s10875-024-01678-w","type":"journal-article","created":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T06:29:26Z","timestamp":1709879366000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Parental Engagement in Identifying Information Needs After Newborn Screening for Families of Infants with Suspected Athymia"],"prefix":"10.1007","volume":"44","author":[{"given":"Evey","family":"Howley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarja","family":"Soomann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra Y.","family":"Kreins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,8]]},"reference":[{"key":"1678_CR1","doi-asserted-by":"publisher","unstructured":"Fischer A, Notarangelo LD, Neven B, Cavazzana M, Puck JM. Severe combined immunodeficiencies and related disorders. Nature reviews Disease primers. 2015;1:15061.\u00a0https:\/\/doi.org\/10.1038\/nrdp.2015.61.","DOI":"10.1038\/nrdp.2015.61"},{"key":"1678_CR2","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1001\/jama.2009.1806","volume":"302","author":"JM Routes","year":"2009","unstructured":"Routes JM, Grossman WJ, Verbsky J, Laessig RH, Hoffman GL, Brokopp CD, et al. Statewide newborn screening for severe T-Cell Lymphopenia. JAMA. 2009;302:2465\u201370.","journal-title":"JAMA"},{"key":"1678_CR3","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jaci.2004.10.012","volume":"115","author":"K Chan","year":"2005","unstructured":"Chan K, Puck JM. Development of population-based newborn screening for severe combined immunodeficiency. J Allergy Clin Immunol. 2005;115:391\u20138.","journal-title":"J Allergy Clin Immunol"},{"key":"1678_CR4","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jaci.2012.01.032","volume":"129","author":"JM Puck","year":"2012","unstructured":"Puck JM. Laboratory technology for population-based screening for severe combined immunodeficiency in neonates: the winner is T-cell receptor excision circles. J Allergy Clin Immunol. 2012;129:607\u201316.","journal-title":"J Allergy Clin Immunol"},{"key":"1678_CR5","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jaci.2020.10.020","volume":"147","author":"R Currier","year":"2021","unstructured":"Currier R, Puck JM. SCID newborn screening: what we\u2019ve learned. J Allergy Clin Immunol. 2021;147:417\u201326.","journal-title":"J Allergy Clin Immunol"},{"key":"1678_CR6","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.jaci.2021.08.026","volume":"149","author":"M Blom","year":"2022","unstructured":"Blom M, Zetterstr\u00f6m RH, Stray-Pedersen A, Gilmour K, Gennery AR, Puck JM, et al. Recommendations for uniform definitions used in newborn screening for severe combined immunodeficiency. J Allergy Clin Immunol. 2022;149:1428\u201336.","journal-title":"J Allergy Clin Immunol"},{"key":"1678_CR7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0140-6736(23)00731-6","volume":"402","author":"MS Thakar","year":"2023","unstructured":"Thakar MS, Logan BR, Puck JM, Dunn EA, Buckley RH, Cowan MJ, et al. Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the primary Immune Deficiency Treatment Consortium. Lancet. 2023;402:129\u201340.","journal-title":"Lancet"},{"key":"1678_CR8","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jaci.2022.10.022","volume":"151","author":"CC Dvorak","year":"2023","unstructured":"Dvorak CC, Haddad E, Heimall J, Dunn E, Buckley RH, Kohn DB, et al. The diagnosis of severe combined immunodeficiency (SCID): the primary Immune Deficiency Treatment Consortium (PIDTC) 2022 definitions. J Allergy Clin Immunol. 2023;151:539\u201346.","journal-title":"J Allergy Clin Immunol"},{"key":"1678_CR9","doi-asserted-by":"publisher","unstructured":"Tr\u00fcck J, Prader S, Natalucci G, Hagmann C, Brotschi B, Kelly J et al. Swiss newborn screening for severe T and B cell deficiency with a combined TREC\/KREC assay \u2013 management recommendations. Swiss Medical Weekly.\u00a02020;150:w20254.\u00a0https:\/\/doi.org\/10.4414\/smw.2020.20254.","DOI":"10.4414\/smw.2020.20254"},{"key":"1678_CR10","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s10875-020-00865-9","volume":"41","author":"MJ Dorsey","year":"2021","unstructured":"Dorsey MJ, Wright NAM, Chaimowitz NS, Salda\u00f1a BJD, Miller H, Keller MD, et al. Infections in infants with SCID: isolation, infection screening, and Prophylaxis in PIDTC centers. J Clin Immunol. 2021;41:38\u201350.","journal-title":"J Clin Immunol"},{"key":"1678_CR11","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jaci.2018.08.027","volume":"143","author":"CC Dvorak","year":"2019","unstructured":"Dvorak CC, Haddad E, Buckley RH, Cowan MJ, Logan B, Griffith LM, et al. The genetic landscape of severe combined immunodeficiency in the United States and Canada in the current era (2010\u20132018). J Allergy Clin Immunol. 2019;143:405\u20137.","journal-title":"J Allergy Clin Immunol"},{"key":"1678_CR12","doi-asserted-by":"publisher","unstructured":"Amatuni GS, Currier RJ, Church JA, Bishop T, Grimbacher E, Nguyen AAC et al. Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California, 2010\u20132017. Pediatrics.\u00a02019;143(2):e20182300.\u00a0https:\/\/doi.org\/10.1542\/peds.2018-2300.","DOI":"10.1542\/peds.2018-2300"},{"key":"1678_CR13","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1007\/s10875-021-01020-8","volume":"41","author":"M Kitcharoensakkul","year":"2021","unstructured":"Kitcharoensakkul M, Aluri J, Elsharkawi I, Steed A, Putnam CD, Swayampakula AK, et al. A case of severe combined immunodeficiency missed by Newborn Screening. J Clin Immunol. 2021;41:1352\u20135.","journal-title":"J Clin Immunol"},{"key":"1678_CR14","doi-asserted-by":"publisher","unstructured":"Speckmann C, Nennstiel U, H\u00f6nig M, Albert MH, Ghosh S, Schuetz C et al. Prospective newborn screening for SCID in Germany: a first analysis by the Pediatric Immunology Working Group (API). J Clin Immunol. 2023;43(5):965\u2013978. https:\/\/doi.org\/10.1007\/s10875-023-01450-6.","DOI":"10.1007\/s10875-023-01450-6"},{"key":"1678_CR15","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.jaip.2017.02.009","volume":"5","author":"AA Mauracher","year":"2017","unstructured":"Mauracher AA, Pagliarulo F, Faes L, Vavassori S, G\u00fcng\u00f6r T, Bachmann LM, et al. Causes of low neonatal T-cell receptor excision circles: a systematic review. J Allergy Clin Immunol Pract. 2017;5:1457-1460e22.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1678_CR16","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00281-020-00826-9","volume":"43","author":"AY Kreins","year":"2021","unstructured":"Kreins AY, Maio S, Dhalla F. Inborn errors of thymic stromal cell development and function. Semin Immunopathol. 2021;43:85\u2013100.","journal-title":"Semin Immunopathol"},{"key":"1678_CR17","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.jaci.2017.03.020","volume":"140","author":"EG Davies","year":"2017","unstructured":"Davies EG, Cheung M, Gilmour K, Maimaris J, Curry J, Furmanski A, et al. Thymus transplantation for complete DiGeorge syndrome: European experience. J Allergy Clin Immunol. 2017;140:1660-1670e16.","journal-title":"J Allergy Clin Immunol"},{"key":"1678_CR18","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jaci.2021.06.028","volume":"149","author":"ML Markert","year":"2022","unstructured":"Markert ML, Gupton SE, McCarthy EA. Experience with cultured thymus tissue in 105 children. J Allergy Clin Immunol. 2022;149:747\u201357.","journal-title":"J Allergy Clin Immunol"},{"key":"1678_CR19","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/jmg.34.10.798","volume":"34","author":"AK Ryan","year":"1997","unstructured":"Ryan AK, Goodship JA, Wilson DI, Philip N, Levy A, Seidel H, et al. Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J Med Genet. 1997;34:798\u2013804.","journal-title":"J Med Genet"},{"key":"1678_CR20","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1182\/blood.2018885244","volume":"133","author":"G Giardino","year":"2019","unstructured":"Giardino G, Radwan N, Koletsi P, Morrogh DM, Adams S, Ip W, et al. Clinical and immunological features in a cohort of patients with partial DiGeorge syndrome followed at a single center. Blood. 2019;133:2586\u201396.","journal-title":"Blood"},{"key":"1678_CR21","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.jpeds.2014.01.056","volume":"164","author":"C Cancrini","year":"2014","unstructured":"Cancrini C, Puliafito P, Digilio MC, Soresina A, Martino S, Rondelli R, et al. Clinical features and follow-up in patients with 22q11.2 deletion syndrome. J Pediatr. 2014;164:1475-1480e2.","journal-title":"J Pediatr"},{"key":"1678_CR22","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/imr.12701","volume":"287","author":"KE Sullivan","year":"2019","unstructured":"Sullivan KE. Chromosome 22q11.2 deletion syndrome and DiGeorge syndrome. Immunol Rev. 2019;287:186\u2013201.","journal-title":"Immunol Rev"},{"key":"1678_CR23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2249.2008.03681.x","volume":"153","author":"AR Gennery","year":"2008","unstructured":"Gennery AR, Slatter MA, Rice J, Hoefsloot LH, Barge D, McLean-Tooke A, et al. Mutations in CHD7 in patients with CHARGE syndrome cause T-B\u2009+\u2009natural killer cell\u2009+\u2009severe combined immune deficiency and may cause Omenn-Like syndrome. Clin Exp Immunol. 2008;153:75\u201380.","journal-title":"Clin Exp Immunol"},{"key":"1678_CR24","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0022-3476(81)80454-4","volume":"99","author":"RA Pagon","year":"1981","unstructured":"Pagon RA, Graham JM, Zonana J, Yong SL. Coloboma, congenital heart disease, and choanal atresia with multiple anomalies: CHARGE association. J Pediatr. 1981;99:223\u20137.","journal-title":"J Pediatr"},{"key":"1678_CR25","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/humu.22086","volume":"33","author":"N Janssen","year":"2012","unstructured":"Janssen N, Bergman JEH, Swertz MA, Tranebjaerg L, Lodahl M, Schoots J, et al. Mutation update on the CHD7 gene involved in CHARGE syndrome. Hum Mutat. 2012;33:1149\u201360.","journal-title":"Hum Mutat"},{"key":"1678_CR26","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1038\/ejhg.2015.7","volume":"23","author":"MTY Wong","year":"2015","unstructured":"Wong MTY, Sch\u00f6lvinck EH, Lambeck AJA, van Ravenswaaij-Arts CMA. CHARGE syndrome: a review of the immunological aspects. Eur J Hum Genet. 2015;23:1451\u20139.","journal-title":"Eur J Hum Genet"},{"key":"1678_CR27","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/ajmg.c.31594","volume":"175","author":"S Mehr","year":"2017","unstructured":"Mehr S, Hsu P, Campbell D. Immunodeficiency in CHARGE syndrome. Am J Med Genet C Semin Med Genet. 2017;175:516\u201323.","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"1678_CR28","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s11689-022-09459-5","volume":"14","author":"AT Thomas","year":"2022","unstructured":"Thomas AT, Waite J, Williams CA, Kirk J, Oliver C, Richards C. Phenotypic characteristics and variability in CHARGE syndrome: a PRISMA compliant systematic review and meta-analysis. J Neurodev Disord. 2022;14:49.","journal-title":"J Neurodev Disord"},{"key":"1678_CR29","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jaci.2020.11.007","volume":"147","author":"A Colmenero-Vel\u00e1zquez","year":"2021","unstructured":"Colmenero-Vel\u00e1zquez A, Esteso G, Del Rosal T, Calvo Apalategui A, Reyburn H, L\u00f3pez-Granados E. Marked changes in innate immunity associated with a mild course of COVID-19 in identical twins with athymia and absent circulating T cells. J Allergy Clin Immunol. 2021;147:567\u20138.","journal-title":"J Allergy Clin Immunol"},{"key":"1678_CR30","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/S0140-6736(03)14632-6","volume":"362","author":"H Yagi","year":"2003","unstructured":"Yagi H, Furutani Y, Hamada H, Sasaki T, Asakawa S, Minoshima S, et al. Role of TBX1 in human del22q11.2 syndrome. Lancet. 2003;362:1366\u201373.","journal-title":"Lancet"},{"key":"1678_CR31","doi-asserted-by":"crossref","first-page":"e91598","DOI":"10.1371\/journal.pone.0091598","volume":"9","author":"T Ogata","year":"2014","unstructured":"Ogata T, Niihori T, Tanaka N, Kawai M, Nagashima T, Funayama R, et al. TBX1 mutation identified by Exome sequencing in a Japanese family with 22q11.2 deletion syndrome-like Craniofacial features and Hypocalcemia. PLoS ONE. 2014;9:e91598.","journal-title":"PLoS ONE"},{"key":"1678_CR32","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1297\/cpe.27.159","volume":"27","author":"K Hasegawa","year":"2018","unstructured":"Hasegawa K, Tanaka H, Higuchi Y, Hayashi Y, Kobayashi K, Tsukahara H. Novel heterozygous mutation in TBX1 in an infant with hypocalcemic seizures. Clin Pediatr Endocrinol. 2018;27:159\u201364.","journal-title":"Clin Pediatr Endocrinol"},{"key":"1678_CR33","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1210\/jc.2018-01260","volume":"103","author":"D Li","year":"2018","unstructured":"Li D, Gordon CT, Oufadem M, Amiel J, Kanwar HS, Bakay M, et al. Heterozygous mutations in TBX1 as a cause of isolated hypoparathyroidism. J Clin Endocrinol Metab. 2018;103:4023\u201332.","journal-title":"J Clin Endocrinol Metab"},{"key":"1678_CR34","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.3389\/fimmu.2021.734096","volume":"12","author":"V Mantravadi","year":"2021","unstructured":"Mantravadi V, Bednarski JJ, Ritter MA, Gu H, Kolicheski AL, Horner C, et al. Immunological findings and clinical outcomes of infants with positive newborn screening for severe combined immunodeficiency from a Tertiary Care Center in the U.S. Front Immunol. 2021;12:3626.","journal-title":"Front Immunol"},{"key":"1678_CR35","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1093\/hmg\/ddy146","volume":"27","author":"N Liu","year":"2018","unstructured":"Liu N, Schoch K, Luo X, Pena LDM, Bhavana VH, Kukolich MK, et al. Functional variants in TBX2 are associated with a syndromic cardiovascular and skeletal developmental disorder. Hum Mol Genet. 2018;27:2454\u201365.","journal-title":"Hum Mol Genet"},{"key":"1678_CR36","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/ng0896-458","volume":"13","author":"SC Daw","year":"1996","unstructured":"Daw SC, Taylor C, Kraman M, Call K, Mao J, Schuffenhauer S, et al. A common region of 10p deleted in DiGeorge and velocardiofacial syndromes. Nat Genet. 1996;13:458\u201360.","journal-title":"Nat Genet"},{"key":"1678_CR37","first-page":"59","volume":"10","author":"H Van Esch","year":"1999","unstructured":"Van Esch H, Groenen P, Fryns JP, Van de Ven W, Devriendt K. The phenotypic spectrum of the 10p deletion syndrome versus the classical DiGeorge syndrome. Genet Couns. 1999;10:59\u201365.","journal-title":"Genet Couns"},{"key":"1678_CR38","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/ajmg.1320520107","volume":"52","author":"M Shapira","year":"1994","unstructured":"Shapira M, Borochowitz Z, Bar-El H, Dar H, Etzioni A, Lorber A. Deletion of the short arm of chromosome 10 (10p13): report of a patient and review. Am J Med Genet. 1994;52:34\u20138.","journal-title":"Am J Med Genet"},{"key":"1678_CR39","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jaci.2019.09.020","volume":"145","author":"JD Bernstock","year":"2020","unstructured":"Bernstock JD, Totten AH, Elkahloun AG, Johnson KR, Hurst AC, Goldman F, et al. Recurrent microdeletions at chromosome 2p11.2 are associated with thymic hypoplasia and features resembling DiGeorge syndrome. J Allergy Clin Immunol. 2020;145:358-367e2.","journal-title":"J Allergy Clin Immunol"},{"key":"1678_CR40","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/(SICI)1096-8628(19961016)65:2<167::AID-AJMG17>3.0.CO;2-O","volume":"65","author":"C Pignata","year":"1996","unstructured":"Pignata C, Fiore M, Guzzetta V, Castaldo A, Sebastio G, Porta F, et al. Congenital Alopecia and nail dystrophy associated with severe functional T-cell immunodeficiency in two sibs. Am J Med Genet. 1996;65:167\u201370.","journal-title":"Am J Med Genet"},{"key":"1678_CR41","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1182\/blood-2010-06-292490","volume":"117","author":"ML Markert","year":"2011","unstructured":"Markert ML, Marques JG, Neven B, Devlin BH, McCarthy EA, Chinn IK, et al. First use of thymus transplantation therapy for FOXN1 deficiency (nude\/SCID): a report of 2 cases. Blood. 2011;117:688\u201396.","journal-title":"Blood"},{"key":"1678_CR42","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1007\/s10875-021-00967-y","volume":"41","author":"G Giardino","year":"2021","unstructured":"Giardino G, Sharapova SO, Ciznar P, Dhalla F, Maragliano L, Radha Rama Devi A, et al. Expanding the Nude SCID\/CID phenotype Associated with FOXN1 homozygous, compound heterozygous, or heterozygous mutations. J Clin Immunol. 2021;41:756\u201368.","journal-title":"J Clin Immunol"},{"key":"1678_CR43","doi-asserted-by":"crossref","first-page":"4724","DOI":"10.1172\/JCI127565","volume":"129","author":"Q Du","year":"2019","unstructured":"Du Q, Huynh LK, Coskun F, Molina E, King MA, Raj P, et al. FOXN1 compound heterozygous mutations cause selective thymic hypoplasia in humans. J Clin Invest. 2019;129:4724\u201338.","journal-title":"J Clin Invest"},{"key":"1678_CR44","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ajhg.2019.07.014","volume":"105","author":"M Bosticardo","year":"2019","unstructured":"Bosticardo M, Yamazaki Y, Cowan J, Giardino G, Corsino C, Scalia G, et al. Heterozygous FOXN1 variants cause low TRECs and severe T cell Lymphopenia, revealing a crucial role of FOXN1 in supporting early thymopoiesis. Am J Hum Genet. 2019;105:549\u201361.","journal-title":"Am J Hum Genet"},{"key":"1678_CR45","doi-asserted-by":"crossref","first-page":"eaax1036","DOI":"10.1126\/sciimmunol.aax1036","volume":"5","author":"Y Yamazaki","year":"2020","unstructured":"Yamazaki Y, Urrutia R, Franco LM, Giliani S, Zhang K, Alazami AM, et al. PAX1 is essential for development and function of the human thymus. Sci Immunol. 2020;5:eaax1036.","journal-title":"Sci Immunol"},{"key":"1678_CR46","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/cge.13085","volume":"92","author":"I Paganini","year":"2017","unstructured":"Paganini I, Sestini R, l Capone G, l Putignano A, Contini E, Giotti I, et al. A novel PAX1 null homozygous mutation in autosomal recessive otofaciocervical syndrome associated with severe combined immunodeficiency. Clin Genet. 2017;92:664\u20138.","journal-title":"Clin Genet"},{"key":"1678_CR47","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s10875-023-01478-8","volume":"43","author":"AY Kreins","year":"2023","unstructured":"Kreins AY, Worth A, Ghosh S, Mohammed RW, Davies EG. First use of thymus transplantation in PAX1 deficiency. J Clin Immunol. 2023;43:1127\u201330.","journal-title":"J Clin Immunol"},{"key":"1678_CR48","doi-asserted-by":"crossref","first-page":"109757","DOI":"10.1016\/j.clim.2023.109757","volume":"255","author":"N Yakici","year":"2023","unstructured":"Yakici N, Kreins AY, Catak MC, Babayeva R, Erman B, Kenney H, et al. Expanding the clinical and immunological phenotypes of PAX1-deficient SCID and CID patients. Clin Immunol. 2023;255:109757.","journal-title":"Clin Immunol"},{"key":"1678_CR49","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.jaci.2022.08.005","volume":"150","author":"R Ghosh","year":"2022","unstructured":"Ghosh R, Bosticardo M, Singh S, Similuk M, Delmonte OM, Pala F, et al. FOXI3 haploinsufficiency contributes to low T-cell receptor excision circles and T-cell lymphopenia. J Allergy Clin Immunol. 2022;150:1556\u201362.","journal-title":"J Allergy Clin Immunol"},{"key":"1678_CR50","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1038\/s41467-023-37703-6","volume":"14","author":"K Mao","year":"2023","unstructured":"Mao K, Borel C, Ansar M, Jolly A, Makrythanasis P, Froehlich C, et al. FOXI3 pathogenic variants cause one form of craniofacial microsomia. Nat Commun. 2023;14:2026.","journal-title":"Nat Commun"},{"key":"1678_CR51","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/ajmg.1320470729","volume":"47","author":"TA Wilson","year":"1993","unstructured":"Wilson TA, Blethen SL, Vallone A, Alenick DS, Nolan P, Katz A, et al. DiGeorge anomaly with renal agenesis in infants of mothers with diabetes. Am J Med Genet. 1993;47:1078\u201382.","journal-title":"Am J Med Genet"},{"key":"1678_CR52","first-page":"471","volume":"37","author":"S Gosseye","year":"1982","unstructured":"Gosseye S, Golaire MC, Verellen G, Van Lierde M, Claus D. Association of bilateral renal agenesis and Di George syndrome in an infant of a diabetic mother. Helv Paediatr Acta. 1982;37:471\u20134.","journal-title":"Helv Paediatr Acta"},{"issue":"23","key":"1678_CR53","first-page":"01114","volume":"S0091\u20136749","author":"E Howley","year":"2023","unstructured":"Howley E, Golwala Z, Buckland M, Barzaghi F, Ghosh S, Hackett S, et al. Impact of newborn screening for SCID on the management of congenital athymia. J Allergy Clin Immunol. 2023;S0091\u20136749(23):01114\u20134.","journal-title":"J Allergy Clin Immunol"},{"key":"1678_CR54","doi-asserted-by":"crossref","first-page":"e1016","DOI":"10.1002\/mgg3.1016","volume":"7","author":"A Martin-Nalda","year":"2019","unstructured":"Martin-Nalda A, Cueto-Gonz\u00e1lez AM, Argudo-Ram\u00edrez A, Marin-Soria JL, Martinez-Gallo M, Colobran R, et al. Identification of 22q11.2 deletion syndrome via newborn screening for severe combined immunodeficiency. Two years\u2019 experience in Catalonia (Spain). Mol Genet Genomic Med. 2019;7:e1016.","journal-title":"Mol Genet Genomic Med"},{"key":"1678_CR55","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2147\/TCRM.S379673","volume":"19","author":"E Howley","year":"2023","unstructured":"Howley E, Davies EG, Kreins AY. Congenital Athymia: unmet needs and practical guidance. Ther Clin Risk Manag. 2023;19:239\u201354.","journal-title":"Ther Clin Risk Manag"},{"key":"1678_CR56","doi-asserted-by":"crossref","first-page":"780140","DOI":"10.3389\/fimmu.2021.780140","volume":"12","author":"J Nordin","year":"2021","unstructured":"Nordin J, Sol\u00eds L, Pr\u00e9vot J, Mahlaoui N, Chapel H, S\u00e1nchez-Ram\u00f3n S, et al. The PID principles of care: where are we now? A global status report based on the PID life index. Front Immunol. 2021;12:780140.","journal-title":"Front Immunol"},{"key":"1678_CR57","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10875-023-01640-2","volume":"44","author":"M Soomann","year":"2024","unstructured":"Soomann M, Prader S, Pinto Monteiro A, Zeilhofer U, Hauri-Hohl M, G\u00fcng\u00f6r T, et al. Reducing mortality and morbidity in children with severe combined immunodeficiency in Switzerland: the role of newborn screening. J Clin Immunol. 2024;44:39.","journal-title":"J Clin Immunol"},{"key":"1678_CR58","doi-asserted-by":"crossref","unstructured":"Raspa M, Kutsa O, Andrews SM, Gwaltney AY, Mallonee E, Creamer A et al. Uncertainties experienced by parents of children diagnosed with severe combined immunodeficiency through newborn screening. Eur J Hum Genet. 2023;1\u20137.","DOI":"10.1038\/s41431-023-01345-5"},{"key":"1678_CR59","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10875-020-00886-4","volume":"41","author":"M Blom","year":"2021","unstructured":"Blom M, Bredius RGM, Jansen ME, Weijman G, Kemper EA, Vermont CL, et al. Parents\u2019 perspectives and societal acceptance of implementation of newborn screening for SCID in the Netherlands. J Clin Immunol. 2021;41:99\u2013108.","journal-title":"J Clin Immunol"},{"key":"1678_CR60","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13073-023-01240-0","volume":"15","author":"AT Pagnamenta","year":"2023","unstructured":"Pagnamenta AT, Camps C, Giacopuzzi E, Taylor JM, Hashim M, Calpena E, et al. Structural and non-coding variants increase the diagnostic yield of clinical whole genome sequencing for rare diseases. Genome Med. 2023;15:94.","journal-title":"Genome Med"},{"key":"1678_CR61","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41586-020-2265-1","volume":"583","author":"JED Thaventhiran","year":"2020","unstructured":"Thaventhiran JED, Lango Allen H, Burren OS, Rae W, Greene D, Staples E, et al. Whole-genome sequencing of a sporadic primary immunodeficiency cohort. Nature. 2020;583:90\u20135.","journal-title":"Nature"},{"key":"1678_CR62","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nmeth.4237","volume":"14","author":"CS Seet","year":"2017","unstructured":"Seet CS, He C, Bethune MT, Li S, Chick B, Gschweng EH, et al. Generation of mature T cells from human hematopoietic stem and progenitor cells in artificial thymic organoids. Nat Methods. 2017;14:521\u201330.","journal-title":"Nat Methods"},{"key":"1678_CR63","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1182\/bloodadvances.2020001736","volume":"4","author":"P Bifsha","year":"2020","unstructured":"Bifsha P, Leiding JW, Pai S-Y, Colamartino ABL, Hartog N, Church JA, et al. Diagnostic assay to assist clinical decisions for unclassified severe combined immune deficiency. Blood Adv. 2020;4:2606\u201310.","journal-title":"Blood Adv"},{"key":"1678_CR64","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.bcmd.2011.04.001","volume":"47","author":"EM Six","year":"2011","unstructured":"Six EM, Benjelloun F, Garrigue A, Bonhomme D, Morillon E, Rouiller J, et al. Cytokines and culture medium have a major impact on human in vitro T-cell differentiation. Blood Cells Mol Dis. 2011;47:72\u20138.","journal-title":"Blood Cells Mol Dis"},{"key":"1678_CR65","unstructured":"Overview | Community engagement: improving health and wellbeing and reducing health inequalities | Guidance | NICE [Internet]. NICE. ; 2016 [cited 2023 Nov 24]. Available from: https:\/\/www.nice.org.uk\/guidance\/ng44."},{"key":"1678_CR66","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s40900-022-00372-8","volume":"8","author":"A Rahman","year":"2022","unstructured":"Rahman A, Nawaz S, Khan E, Islam S. Nothing about us, without us: is for us. Res Involv Engagem. 2022;8:39.","journal-title":"Res Involv Engagem"},{"key":"1678_CR67","doi-asserted-by":"crossref","first-page":"e1523","DOI":"10.1002\/cnr2.1523","volume":"5","author":"A Polanco","year":"2022","unstructured":"Polanco A, Al-Saadi R, Tugnait S, Scobie N, Pritchard-Jones K. Setting international standards for patient and parent involvement and engagement in childhood, adolescent and young adult cancer research: a report from a European collaborative workshop. Cancer Rep (Hoboken). 2022;5:e1523.","journal-title":"Cancer Rep (Hoboken)"},{"key":"1678_CR68","unstructured":"NIHR. Going the extra mile: Improving the nation\u2019s health and wellbeing through public involvement in research. [Internet]. [cited 2023 Dec 19]. Available from: https:\/\/www.nihr.ac.uk\/documents\/about-us\/our-contribution-to-research\/how-we-involve-patients-carers-and-the-public\/Going-the-Extra-Mile.pdf."},{"key":"1678_CR69","doi-asserted-by":"crossref","first-page":"91","DOI":"10.35680\/2372-0247.1294","volume":"5","author":"SK Featherston","year":"2018","unstructured":"Featherston SK, Rozo BN, Buzanga DA, Garcia AM, Greene J, Salvador LK, et al. Integrating the patient and caregiver voice in the context of pediatric, adolescent, and young adult care: a family-centered approach. Patient Exp J. 2018;5:91\u20136.","journal-title":"Patient Exp J"},{"key":"1678_CR70","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1136\/bmjqs-2015-004839","volume":"25","author":"J Ocloo","year":"2016","unstructured":"Ocloo J, Matthews R. From tokenism to empowerment: progressing patient and public involvement in healthcare improvement. BMJ Qual Saf. 2016;25:626\u201332.","journal-title":"BMJ Qual Saf"},{"key":"1678_CR71","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1038\/s41591-023-02445-x","volume":"29","author":"OL Aiyegbusi","year":"2023","unstructured":"Aiyegbusi OL, McMullan C, Hughes SE, Turner GM, Subramanian A, Hotham R, et al. Considerations for patient and public involvement and engagement in health research. Nat Med. 2023;29:1922\u20139.","journal-title":"Nat Med"},{"key":"1678_CR72","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1186\/s12887-019-1742-x","volume":"19","author":"H Piercy","year":"2019","unstructured":"Piercy H, Yeo M, Yap S, Hart AR. What are the information needs of parents caring for a child with glutaric aciduria type 1? BMC Pediatr. 2019;19:349.","journal-title":"BMC Pediatr"},{"key":"1678_CR73","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3390\/ijns5020023","volume":"5","author":"F Johnson","year":"2019","unstructured":"Johnson F, Southern KW, Ulph F. Psychological impact on parents of an inconclusive diagnosis following newborn Bloodspot screening for cystic fibrosis: a qualitative study. Int J Neonatal Screen. 2019;5:23.","journal-title":"Int J Neonatal Screen"},{"key":"1678_CR74","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00431-019-03479-5","volume":"179","author":"MHD Schoenaker","year":"2020","unstructured":"Schoenaker MHD, Blom M, de Vries MC, Weemaes CMR, van der Burg M, Willemsen MAAP. Early diagnosis of ataxia telangiectasia in the neonatal phase: a parents\u2019 perspective. Eur J Pediatr. 2020;179:251\u20136.","journal-title":"Eur J Pediatr"},{"key":"1678_CR75","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3389\/fimmu.2020.00885","volume":"11","author":"M Raspa","year":"2020","unstructured":"Raspa M, Lynch M, Squiers L, Gwaltney A, Porter K, Peay H, et al. Information and emotional support needs of families whose infant was diagnosed with SCID through Newborn Screening. Front Immunol. 2020;11:885.","journal-title":"Front Immunol"},{"key":"1678_CR76","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/ajmg.c.31884","volume":"187","author":"BC Miller","year":"2021","unstructured":"Miller BC, Goldenberg AJ, Bonhomme NF. Digital peer-to-peer information seeking and sharing: opportunities for education and collaboration in newborn screening. Am J Med Genet C Semin Med Genet. 2021;187:64\u20139.","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"1678_CR77","first-page":"A17","volume":"104","author":"E Howley","year":"2019","unstructured":"Howley E, Kreins A, Worth A, Davies G. 40 educating families through purposefully designed patient information for the thymus transplant pathway. Arch Dis Child. 2019;104:A17-7.","journal-title":"Arch Dis Child"},{"key":"1678_CR78","doi-asserted-by":"crossref","first-page":"e13415","DOI":"10.1111\/ecc.13415","volume":"30","author":"H Kerr","year":"2021","unstructured":"Kerr H, Donovan M, McSorley O. Evaluation of the role of the clinical nurse specialist in cancer care: an integrative literature review. Eur J Cancer Care (Engl). 2021;30:e13415.","journal-title":"Eur J Cancer Care (Engl)"},{"key":"1678_CR79","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.outlook.2020.06.004","volume":"68","author":"MF Tracy","year":"2020","unstructured":"Tracy MF, Oerther S, Arslanian-Engoren C, Girouard S, Minarik P, Patrician P, et al. Improving the care and health of populations through optimal use of clinical nurse specialists. Nurs Outlook. 2020;68:523\u20137.","journal-title":"Nurs Outlook"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-024-01678-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-024-01678-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-024-01678-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T11:18:59Z","timestamp":1713871139000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-024-01678-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,8]]},"references-count":79,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["1678"],"URL":"https:\/\/doi.org\/10.1007\/s10875-024-01678-w","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,8]]},"assertion":[{"value":"23 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original version of this paper was updated due to revised supplementary material.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"EH is supported by LetterOne in conjunction with Great Ormond Street Children\u2019s Charity. MS is supported by the Georg und Bertha Schwyzer-Winiker Foundation, the Wolfermann-N\u00e4geli Foundation and the EMDO Foundation. AYK is supported by the Wellcome Trust (222096\/Z\/20\/Z). PPIE activities at GOSH are supported by NIHR Great Ormond Street Hospital Biomedical Research Centre (GOSH BRC).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial Support and Sponsorship"}},{"value":"No ethical approval was needed for this PPIE project. Participants consented for their participation in the sessions and the use of anonymised data and quotes in publication.\u00a0","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and Consent to Participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"79"}}